Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof
US10179817B2 · kind B2 · utility
25Cited by
18References
58Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2016 |
| Grant date | Jan 15, 2019 |
| Priority date | — |
| Expiry date | May 4, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates generally to antibodies that bind CD71, activatable antibodies that specifically bind to CD71 and methods of making and using these anti-CD71 antibodies and anti-CD71 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.